Bank of America’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $126M | Sell |
350,482
-31,331
| -8% | -$9.58M | 0.01% | 1033 |
|
|
2026
Q1 | $95.7M | Sell |
381,813
-150,033
| -28% | -$37.3M | 0.01% | 1151 |
|
|
2025
Q4 | $146M | Buy |
531,846
+57,640
| +12% | +$15.8M | 0.01% | 892 |
|
|
2025
Q3 | $124M | Sell |
474,206
-25,929
| -5% | -$6.3M | 0.01% | 1072 |
|
|
2025
Q2 | $109M | Sell |
500,135
-11,150
| -2% | -$2.38M | 0.01% | 1093 |
|
|
2025
Q1 | $114M | Buy |
511,285
+123,430
| +32% | +$34M | 0.01% | 1010 |
|
|
2024
Q4 | $127M | Sell |
387,855
-39,014
| -9% | -$12.3M | 0.01% | 904 |
|
|
2024
Q3 | $128M | Sell |
426,869
-104,512
| -20% | -$32M | 0.01% | 934 |
|
|
2024
Q2 | $175M | Buy |
531,381
+3,085
| +0.6% | +$1.09M | 0.02% | 732 |
|
|
2024
Q1 | $209M | Buy |
528,296
+31,923
| +6% | +$11.8M | 0.02% | 666 |
|
|
2023
Q4 | $175M | Sell |
496,373
-59,903
| -11% | -$21.2M | 0.02% | 680 |
|
|
2023
Q3 | $209M | Sell |
556,276
-11,915
| -2% | -$4.61M | 0.02% | 568 |
|
|
2023
Q2 | $217M | Sell |
568,191
-120,170
| -17% | -$42.9M | 0.02% | 573 |
|
|
2023
Q1 | $238M | Buy |
688,361
+102,354
| +17% | +$29.9M | 0.02% | 566 |
|
|
2022
Q4 | $138M | Sell |
586,007
-113,824
| -16% | -$27M | 0.02% | 746 |
|
|
2022
Q3 | $172M | Buy |
699,831
+29,346
| +4% | +$8.94M | 0.02% | 633 |
|
|
2022
Q2 | $203M | Buy |
670,485
+30,853
| +5% | +$10M | 0.02% | 579 |
|
|
2022
Q1 | $263M | Buy |
639,632
+171,554
| +37% | +$67.2M | 0.03% | 543 |
|
|
2021
Q4 | $220M | Sell |
468,078
-24,168
| -5% | -$10.4M | 0.02% | 628 |
|
|
2021
Q3 | $209M | Buy |
492,246
+5,188
| +1% | +$2.19M | 0.02% | 620 |
|
|
2021
Q2 | $175M | Sell |
487,058
-31,678
| -6% | -$10.5M | 0.02% | 686 |
|
|
2021
Q1 | $146M | Sell |
518,736
-57,285
| -10% | -$16.4M | 0.02% | 713 |
|
|
2020
Q4 | $163M | Sell |
576,021
-102,562
| -15% | -$28.8M | 0.02% | 581 |
|
|
2020
Q3 | $187M | Buy |
678,583
+95,427
| +16% | +$25.3M | 0.03% | 515 |
|
|
2020
Q2 | $132M | Buy |
583,156
+29,617
| +5% | +$5.82M | 0.02% | 584 |
|
|
2020
Q1 | $84.3M | Sell |
553,539
-11,140
| -2% | -$1.71M | 0.02% | 697 |
|
|
2019
Q4 | $84.9M | Buy |
564,679
+68,472
| +14% | +$9.97M | 0.01% | 860 |
|
|
2019
Q3 | $70.4M | Sell |
496,207
-61,017
| -11% | -$8.4M | 0.01% | 921 |
|
|
2019
Q2 | $69.7M | Sell |
557,224
-27,685
| -5% | -$3.27M | 0.01% | 921 |
|
|
2019
Q1 | $64.5M | Sell |
584,909
-88,776
| -13% | -$9.23M | 0.01% | 957 |
|
|
2018
Q4 | $66M | Sell |
673,685
-31,541
| -4% | -$3.42M | 0.01% | 854 |
|
|
2018
Q3 | $87.1M | Sell |
705,226
-120,983
| -15% | -$13.6M | 0.01% | 787 |
|
|
2018
Q2 | $82M | Sell |
826,209
-28,935
| -3% | -$2.66M | 0.01% | 783 |
|
|
2018
Q1 | $75.5M | Buy |
855,144
+39,727
| +5% | +$3.72M | 0.01% | 832 |
|
|
2017
Q4 | $80.5M | Sell |
815,417
-41,322
| -5% | -$4.05M | 0.01% | 836 |
|
|
2017
Q3 | $82.5M | Buy |
856,739
+290,853
| +51% | +$26.3M | 0.01% | 862 |
|
|
2017
Q2 | $53.5M | Sell |
565,886
-90,056
| -14% | -$8.28M | 0.01% | 1006 |
|
|
2017
Q1 | $53.5M | Sell |
655,942
-91,399
| -12% | -$7.64M | 0.01% | 1001 |
|
|
2016
Q4 | $63.4M | Sell |
747,341
-16,529
| -2% | -$1.3M | 0.01% | 881 |
|
|
2016
Q3 | $56.9M | Buy |
763,870
+232,261
| +44% | +$18.4M | 0.01% | 903 |
|
|
2016
Q2 | $40.3M | Buy |
531,609
+107,417
| +25% | +$7.82M | 0.01% | 1118 |
|
|
2016
Q1 | $29.4M | Sell |
424,192
-22,253
| -5% | -$1.34M | 0.01% | 1275 |
|
|
2015
Q4 | $26.9M | Buy |
446,445
+14,220
| +3% | +$855K | 0.01% | 1409 |
|
|
2015
Q3 | $23.4M | Buy |
432,225
+207,990
| +93% | +$12.1M | 0.01% | 1500 |
|
|
2015
Q2 | $13M | Buy |
224,235
+54,339
| +32% | +$3.03M | ﹤0.01% | 1707 |
|
|
2015
Q1 | $10.2M | Sell |
169,896
-32,310
| -16% | -$1.72M | ﹤0.01% | 1854 |
|
|
2014
Q4 | $10.8M | Buy |
202,206
+72,494
| +56% | +$3.63M | ﹤0.01% | 1873 |
|
|
2014
Q3 | $5.81M | Buy |
129,712
+11,869
| +10% | +$504K | ﹤0.01% | 2440 |
|
|
2014
Q2 | $4.97M | Sell |
117,843
-20,759
| -15% | -$889K | ﹤0.01% | 2564 |
|
|
2014
Q1 | $6.11M | Sell |
138,602
-52,556
| -27% | -$2.47M | ﹤0.01% | 2222 |
|
|
2013
Q4 | $9.38M | Buy |
191,158
+141,735
| +287% | +$6.63M | ﹤0.01% | 1913 |
|
|
2013
Q3 | $2.03M | Sell |
49,423
-24,581
| -33% | -$938K | ﹤0.01% | 3256 |
|
|
2013
Q2 | $2.6M | Buy |
+74,004
| New | +$2.44M | ﹤0.01% | 2918 |
|
Other funds holding WST
GIM
Bank of America's WST Position: Q2 2026 in Review
Bank of America reduced its West Pharmaceutical (WST) stake by 8.2% in Q2 2026, selling an estimated $9.58M and leaving 350,482 shares worth $126M. The position accounts for 0.01% of the portfolio, ranked #1033.
Bank of America first reported a position in WST in Q2 2013 and has held it in 53 quarters since. The position peaked at $263M in Q1 2022. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.
- Bank of America held 350,482 shares of West Pharmaceutical worth $126M as of Q2 2026.
- Bank of America sold 31,331 West Pharmaceutical shares in Q2 2026, an estimated $9.58M.
- West Pharmaceutical made up 0.01% of Bank of America's portfolio in Q2 2026, its #1033 holding.
- Bank of America first reported a position in West Pharmaceutical in Q2 2013 and has held it in 53 quarters since.
- Bank of America's West Pharmaceutical position peaked at $263M in Q1 2022.
- 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.
Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.